文献速递儿童青少年精神心境障碍焦虑、强迫与应激相关障碍

Shamiri非专业提供者干预对比学习技能对照对肯尼亚青少年抑郁焦虑症状的影响:随机临床试验

Effect of Shamiri Layperson-Provided Intervention vs Study Skills Control Intervention for Depression and Anxiety Symptoms in Adolescents in Kenya: A Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该随机临床试验纳入413名肯尼亚13-18岁抑郁或焦虑症状升高的青少年,比较Shamiri干预与学习技能对照。两组症状均减轻,但Shamiri组在抑郁和焦虑症状上减幅更大,效果至少持续7个月。

要点

  • Shamiri干预在治疗后、2周及7个月随访时抑郁症状减幅均大于学习技能对照。
  • 焦虑症状在治疗后及7个月随访减幅更大,2周随访差异不显著。
  • 两组均高度评价干预有用(4.8/5.0),且症状均减轻。

核心结论

  • Shamiri干预和学习技能对照均减轻抑郁和焦虑症状,但Shamiri干预效果更大且至少持续7个月。

研究设计与样本

  • 研究为基于学校的随机临床试验,纳入肯尼亚内罗毕和基安布县4所中学的413名13-18岁抑郁或焦虑症状升高的青少年。
  • 参与者随机分为Shamiri干预组(205人)和学习技能对照组(208人),两组均以每组平均9人的小组形式每周60分钟、共4周。
  • 主要结局为抑郁(PHQ-8)和焦虑(GAD-7)症状,采用意向性治疗分析和插补数据分析。

主要发现

  • Shamiri组在治疗后抑郁症状减幅优于对照组(Cohen d=0.35,95%CI 0.09-0.60)。
  • Shamiri组在2周随访(Cohen d=0.28,95%CI 0.04-0.54)和7个月随访(Cohen d=0.45,95%CI 0.19-0.71)抑郁症状减幅均更大。
  • Shamiri组在治疗后焦虑症状减幅更大(Cohen d=0.37,95%CI 0.11-0.63)。
  • 2周随访焦虑症状差异不显著(Cohen d=0.26,95%CI -0.01 to 0.53),7个月随访减幅更大(Cohen d=0.44,95%CI 0.18-0.71)。

关键数值与推荐

  • 抑郁症状采用患者健康问卷-8项(PHQ-8)评估,焦虑症状采用广泛性焦虑障碍-7项(GAD-7)评估。
  • 效应量以Cohen d表示,抑郁和焦虑各随访点的95%CI见主要发现。
  • 两组干预有用性评分均为4.8/5.0。

临床怎么用

  • 在资源有限、病耻感或专业人员短缺的环境中,非专业提供者实施的Shamiri干预可作为减轻青少年抑郁和焦虑症状的低成本选择。
  • 需降低失访率并确立结局差异的临床意义后,方可推广至其他全球类似环境。

局限性

  • 原文未明确报告失访率的具体数值,仅提及需减少失访。
  • 结局差异的临床意义尚未确立。
  • 研究仅纳入肯尼亚4所中学的青少年,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Low-cost interventions for adolescent depression and anxiety are needed in low-resource countries such as those in Sub-Saharan Africa. OBJECTIVE: To assess whether Shamiri, a 4-week layperson-delivered group intervention that teaches growth mindset, gratitude, and value affirmation, can alleviate depression and anxiety symptoms in symptomatic Kenyan adolescents. DESIGN, SETTING, AND PARTICIPANTS: This school-based randomized clinical trial included outcomes assessed at baseline, posttreatment, and 2-week and 7-month follow-up from 4 secondary schools in Nairobi and Kiambu County, Kenya. Adolescents aged 13 to 18 years with elevated symptoms on standardized depression or anxiety measures were eligible. Intent-to-treat analyses were used to analyze effects. Recruitment took place in June 2019; follow-up data were collected in August 2019 and February 2020. INTERVENTION: Adolescents were randomized to the Shamiri intervention or to a study skills control. All adolescents in both conditions met in groups (mean group size, 9) for 60 minutes per week for 4 weeks. MAIN OUTCOMES AND MEASURES: Primary outcomes were depression (Patient Health Questionnaire-8 item) and anxiety (Generalized Anxiety Disorder-7 item) symptoms. Analyses of imputed data were hypothesized to reveal significant reductions in depression and anxiety symptoms for adolescents assigned to Shamiri compared with those in the study skills group. RESULTS: Of 413 adolescents, 205 (49.6%) were randomized to Shamiri and 208 (50.4%) to study skills. The mean (SD) age was 15.5 (1.2) years, and 268 (65.21%) were female. A total of 307 youths completed the 4-week intervention. Both Shamiri and study skills were rated highly useful (4.8/5.0) and reduced symptoms of depression and anxiety, but analyses with imputed data revealed that youths receiving Shamiri showed greater reductions in depressive symptoms at posttreatment (Cohen d = 0.35 [95% CI, 0.09-0.60]), 2-week follow-up (Cohen d = 0.28 [95% CI, 0.04-0.54]), and 7-month follow-up (Cohen d = 0.45 [95% CI, 0.19-0.71]) and greater reductions in anxiety symptoms at posttreatment (Cohen d = 0.37 [95% CI, 0.11-0.63]), 2-week follow-up (Cohen d = 0.26 [95% CI, -0.01 to 0.53]), and 7-month follow-up (Cohen d = 0.44 [95% CI, 0.18-0.71]). CONCLUSIONS AND RELEVANCE: Both the Shamiri intervention and a study skills control group reduced depression and anxiety symptoms; the low-cost Shamiri intervention had a greater effect, with effects lasting at least 7 months. If attrition is reduced and the clinical significance of outcome differences is established, this kind of intervention may prove useful in other global settings where there are limited resources, mental illness stigma, or a shortage of professionals and limited access to mental health care. TRIAL REGISTRATION: Pan-African Clinical Trials Registry Identifier: PACTR201906525818462.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Osborn TL, Venturo-Conerly KE, Arango G S, et al. Effect of Shamiri Layperson-Provided Intervention vs Study Skills Control Intervention for Depression and Anxiety Symptoms in Adolescents in Kenya: A Randomized Clinical Trial. JAMA Psychiatry. 2021. PMID: 34106239. doi:10.1001/jamapsychiatry.2021.1129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。